Syeda, M. M., Wiggins, J. M., Corless, B. C., Long, G. V., Flaherty, K. T., Schadendorf, D., . . . Polsky, D. (2021). Clinical validation study of circulating tumour DNA in patients with advanced melanoma treated with dabrafenib or dabrafenib plus trametinib. Lancet Oncol.
Citação norma ChicagoSyeda, Mahrukh M., et al. "Clinical Validation Study of Circulating Tumour DNA in Patients With Advanced Melanoma Treated With Dabrafenib or Dabrafenib Plus Trametinib." Lancet Oncol 2021.
MLA citiranjeSyeda, Mahrukh M., et al. "Clinical Validation Study of Circulating Tumour DNA in Patients With Advanced Melanoma Treated With Dabrafenib or Dabrafenib Plus Trametinib." Lancet Oncol 2021.
Opozorilo: Ti citati niso vedno 100% točni.